La souris comme modèle pour comprendre les maladies humaines

›9:00 (25min)

The Access Platform : a collaborative way to progress early drug discovery projects
Dr. Claudine Grepin

›9:25 (25min)

Generation of germline mutations using ZFN TALE nuclease technology
Pr. Wolfgang Wurst

›9:50 (25min)

Spatio-temporally-controlled targeted somatic mutagenesis in the mouse
Dr. Daniel Metzger

›10:15 (20min)

Mouse models for gene therapy of inherited muscular disorders
Dr. Ana Buj-Bello

›10:35 (25min)

Coffee break

›11:00 (25min)

The IKMC Web Portal: a single access point to mouse knockouts from the International Knockout Mouse Consortium
Dr. Bill Skarnes

›11:25 (25min)

The contribution of mice models toward a cell therapy for diabetes
Dr Gerard Gradwohl

›11:50 (25min)

The International Mouse Phenotyping Consortium
Pr. Steve Brown

›12:15 (1h25)

Lunch

›13:40 (25min)

Opioid receptors and neural disorders: genetic approaches in mice
Dr. Brigitte Kieffer

›14:05 (15min)

Non viral siRNA delivery for cancer treatment
Dr. Anne Laure Bolcato-Bellemin

›14:20 (25min)

Segmentation of the mouse embryo
Dr. Olivier Pourquié

›14:45 (15min)

Correlation of Anatomical Features and Molecular Information by MSI and MRI
Dr. Michael Becker

›15:00 (25min)

Genetic dissection of the molecular and cellular bases of adaptive immunity: from mouse to human.
Dr. Bernard Malissen

›15:25 (35min)

Coffee break

›16:00 (10min)

The genesis of transgenic mice in Strasbourg
Dr. Marianne LeMeur

›16:10 (10min)

From ES to MCI (ICS)
Dr. Andrée Dierich

›16:20 (20min)

PHENOMIN, the way forward
Dr. Yann Hérault